Agostina Nardone

9PUBLICATIONS
145CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 19, 2026
Exploratory Analysis of PTEN Deficiency by Immunohistochemistry from the Phase III CAPItello-291 Trial.

|Dec 22, 2025
ctDNA Detection with Low-Pass Whole-Genome Bisulfite Sequencing in RAS Wild-Type Metastatic Colorectal Cancer: An Exploratory Objective of the VALENTINO Trial.

Paolo Manca, Marta Paoli, Francesca Galardi

|Mar 01, 2024
Mutational Analysis of Circulating Tumor DNA in Patients With Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer Receiving Palbociclib: Results From the TREnd Trial.

Ilenia Migliaccio, Dario Romagnoli, Francesca Galardi

|Feb 21, 2024
Selective CDK7 Inhibition Suppresses Cell Cycle Progression and MYC Signaling While Enhancing Apoptosis in Therapy-resistant Estrogen Receptor-positive Breast Cancer.

Cristina Guarducci, Agostina Nardone, Douglas Russo

|Nov 03, 2023
Mathematical Modeling Identifies Optimum Palbociclib-fulvestrant Dose Administration Schedules for the Treatment of Patients with Estrogen Receptor-positive Breast Cancer.

Yu-Chen Cheng, Shayna Stein, Agostina Nardone

|Jul 14, 2023
Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor-Positive Breast Cancer.

Francisco Hermida-Prado, Yingtian Xie, Shira Sherman

Pageof 2

Frequent Collaborators

5 joint publications

Cristina Guarducci

5 joint publications

Rinath Jeselsohn

3 joint publications

Weihan Liu

3 joint publications

Luca Malorni